These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 3896287)
1. Natural immunity to tumours--theoretical predictions and biological observations. Moore M Br J Cancer; 1985 Aug; 52(2):147-51. PubMed ID: 3896287 [No Abstract] [Full Text] [Related]
2. Natural killer cells in relation to disease and treatment. Pedersen BK Allergy; 1985 Nov; 40(8):547-57. PubMed ID: 3911816 [No Abstract] [Full Text] [Related]
3. Rejection of bone marrow cells by irradiated mice: NK and T cells recognize different antigens. Bennett M; Kumar V; Mikhael A; Murphy WJ; Rembecki RM; Sentman CL; David CS Transplant Proc; 1987 Dec; 19(6 Suppl 7):5-11. PubMed ID: 3321646 [No Abstract] [Full Text] [Related]
4. The role of natural killer cells in human disease. Whiteside TL; Herberman RB Clin Immunol Immunopathol; 1989 Oct; 53(1):1-23. PubMed ID: 2670363 [No Abstract] [Full Text] [Related]
5. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth. Herberman RB Concepts Immunopathol; 1985; 1():96-132. PubMed ID: 3916408 [No Abstract] [Full Text] [Related]
7. Genetic control of natural cytotoxicity and hybrid resistance. Clark EA; Harmon RC Adv Cancer Res; 1980; 31():227-85. PubMed ID: 6157312 [No Abstract] [Full Text] [Related]
8. Role of natural killer cells in host defense against cancer metastasis. Hanna N Symp Fundam Cancer Res; 1983; 36():309-19. PubMed ID: 6382510 [No Abstract] [Full Text] [Related]
11. Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens. Hokland ME Acta Pathol Microbiol Immunol Scand Suppl; 1985; 286():1-35. PubMed ID: 2408439 [No Abstract] [Full Text] [Related]
12. Natural cellular defense activities against tumors--cytostasis and NK activity. Ehrlich R; Efrati M; Gonen B; Shochat L; Witz IP Haematol Blood Transfus; 1983; 28():470-1. PubMed ID: 6862310 [No Abstract] [Full Text] [Related]
13. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms]. Rupniewska ZM; Adamczyk MB Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960 [No Abstract] [Full Text] [Related]
14. New aspects of natural-killer-cell surveillance and therapy of cancer. Smyth MJ; Hayakawa Y; Takeda K; Yagita H Nat Rev Cancer; 2002 Nov; 2(11):850-61. PubMed ID: 12415255 [No Abstract] [Full Text] [Related]
15. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation. Keever CA; Welte K; Sullivan M; O'Reilly RJ Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004 [No Abstract] [Full Text] [Related]
17. MHC-unrestricted immune surveillance of leukemia. Pawelec G Cancer Biother; 1994; 9(3):265-88. PubMed ID: 7820187 [TBL] [Abstract][Full Text] [Related]
18. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes. Ralph P Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440 [No Abstract] [Full Text] [Related]
19. Possible role of natural killer cells and other effector cells in immune surveillance against cancer. Herberman RB J Invest Dermatol; 1984 Jul; 83(1 Suppl):137s-140s. PubMed ID: 6376648 [TBL] [Abstract][Full Text] [Related]